Filling the need for trusted information on national health issues…

Vaccines

  • Your Selections:

Refine Results

date

Tags

Media Sources Report On Various Aspects Of Ebola Drug, Vaccine R&D

Media sources report on various issues surrounding research into Ebola vaccines and treatments. Associated Press: U.S. officials unveil plan to test Ebola drugs (Marchione, 11/5). CIDRAP News: FDA, industry officials vow to minimize barriers to Ebola vaccines (Roos, 11/5). Reuters: U.S. Ebola researchers plead for access to virus samples (Steenhuysen,…

Opinion Pieces Address Ebola Quarantines, Development Of Treatments, Vaccines

New England Journal of Medicine: Panic, Paranoia, and Public Health — The AIDS Epidemic’s Lessons for Ebola Gregg Gonsalves, HIV/AIDS activist and co-director of the Yale Global Health Justice Partnership at Yale Law School and Yale School of Public Health, and Peter Staley, HIV/AIDS activist “For those of us who…

Additional Federal Funding For HIV Vaccine Research Needed, Experts Say At CSIS Event

Media sources report on an event held Tuesday at the Center for Strategic and International Studies, titled “Ending Epidemics Through Technology: Developing an HIV Vaccine.” CQ HealthBeat: Advocates Cite Promising AIDS Vaccine Research in Quest for Funds “AIDS experts said Tuesday that it’s critical to push for higher levels of…

Experimental Hepatitis C Vaccine Safe In Humans, Study Says

News outlets report that an experimental vaccine for hepatitis C has shown to be safe for humans. Los Angeles Times: Experimental hepatitis C vaccine shows promise, researchers say (Morin, 11/5). Reuters: GSK hepatitis C shot shows promise, bodes well for Ebola vaccines (Kelland, 11/5). TIME: Hepatitis C Vaccine Safe In Humans, Study…

Canada’s Tekmira To Produce Experimental Ebola Treatment For U.S. DoD

Reuters: Tekmira to produce Ebola treatment for U.S. Dept of Defense “The U.S. Department of Defense has exercised an option with Canada’s Tekmira Pharmaceuticals Corp. for the company to make 500 courses of its experimental treatment for Ebola, Tekmira said on Thursday. The treatment targets the Ebola-Guinea virus variant, which…

Devex Examines Gavi, The Vaccine Alliance’s Rebranding Efforts

Devex: The evolution of global health’s ‘best-kept secret’ “…[T]hose who are familiar with Gavi believe the organization has been very discreet about its work and could do more to raise awareness about its mission — a point that the survey [of key global health stakeholders] reinforced. Immediately after finding out…

U.S. Should Support Gavi With $250M Annually Over Next 4 Years

The Missoulian: Urge U.S. leaders to support Gavi Carla Mettling, co-chair of the Missoula chapter of RESULTS “…[T]he work of multilateral aid groups gives hope in this dismal picture [of acute and ongoing health emergencies]. One such is Gavi, the Vaccine Alliance, which vaccinates children against the major childhood killers…

Despite Achievements, GAVI Alliance Continues To Face Challenges In Childhood Immunization Efforts

A Lancet editorial discusses the GAVI Alliance’s 2013 Mid-Term Review, released this week, noting the report “examines the organization’s progress midway through the period 2011-15” and states that “by 2014, 73 countries with GAVI’s support will introduce five-in-one pentavalent vaccines, including fragile states — Haiti, Burma, Somalia, and South Sudan.”…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.